Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses. - Wikidata - awgldk - TriplyDB

Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.

Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.

http://www.wikidata.org/entity/Q34594898

about

Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses.Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.cFLIPL Interrupts IRF3-CBP-DNA Interactions To Inhibit IRF3-Driven Transcription.Ebola virus disease candidate vaccines under evaluation in clinical trials.Discrimination of Self and Non-Self Ribonucleic Acids.E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.

P2860

Q36947039-4C4C7C4F-7351-4448-80DE-E19404654A2E Q38741327-87C65D01-ABB8-4495-898D-925F0F97F853 Q38762343-20713233-37AD-4AFE-9B9D-82E2BD4D1F0E Q38830109-F58F2F20-A0DF-4CE2-A4DF-06D2F66D3657 Q40213813-355B492F-E6BC-408F-94E1-83B2837F80B0 Q47233214-65614F69-50C5-4761-A9CF-7BEDCF40FE62

P2860

Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.

http://www.wikidata.org/entity/Q34594898

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Recombinant modified vaccinia ...... anced innate immune responses.

@ast

Recombinant modified vaccinia ...... anced innate immune responses.

@en

Recombinant modified vaccinia ...... anced innate immune responses.

@nl

type

label

Recombinant modified vaccinia ...... anced innate immune responses.

@ast

Recombinant modified vaccinia ...... anced innate immune responses.

@en

Recombinant modified vaccinia ...... anced innate immune responses.

@nl

prefLabel

Recombinant modified vaccinia ...... anced innate immune responses.

@ast

Recombinant modified vaccinia ...... anced innate immune responses.

@en

Recombinant modified vaccinia ...... anced innate immune responses.

@nl

P1433

Q34594898-63766E2C-1151-489B-9E6B-EC504A7E4C7B

P1476

Q34594898-9B1561F5-FC8B-4712-9652-A0E7CD1845AD

P2093

Q34594898-18AD15BE-BE3B-4FEF-BC13-F9AEF357EED8

Q34594898-1A610E36-C24F-4FD5-83C7-E8A7979BDBBF

Q34594898-877DD10E-3F0F-432B-A72A-529DE424E92D

Q34594898-A389F46C-056A-46BD-92F5-2D3E00E03BC9

Q34594898-B50F4069-AB3F-4731-9130-C71765FA7853

Q34594898-B7CE4131-2F3A-49A6-9825-95F77C3D5AF8

Q34594898-BB6FA5ED-274B-4885-974F-818ACECED41F

Q34594898-C4865D32-0088-4454-BDA0-29C362DDF759

Q34594898-C8357464-95B1-4CAB-9E21-F4ED8D6DA5DB

Q34594898-F304ED67-B319-4471-80DE-02D4B40110E8

P2860

Q34594898-0303C9CC-9F7B-4180-BE5A-1B0FEAD747FF

Q34594898-10702F6B-2DF4-4A54-B3FE-989691B865C1

Q34594898-172C285A-2239-4DB5-8647-B6DE7CD30EC2

Q34594898-179278AA-0D6F-430E-9B07-8B466909F9FB

Q34594898-1B2C9714-494F-4F36-AF35-76805F30F0A3

Q34594898-1D2F0D21-86B9-4714-A038-07EFDAB58453

Q34594898-1F9456A6-A667-4579-AC43-F6A255AF7D01

Q34594898-2194CC4C-D6AA-45C1-9550-7682CDE6065A

Q34594898-246D87A2-B03B-4089-B61D-01F2AF519E18

Q34594898-27C740FC-9865-4ECE-84A9-F3526B390AF9

P304

Q34594898-1E784A50-24F2-49D7-A6C3-502E70BD1E6D

P31

Q34594898-5D9E0DD3-E7F3-4E80-B510-D552DBAF909E

P356

Q34594898-39A19F29-7036-4459-B5EC-4E948AF116C6

P407

Q34594898-66B29E29-120E-4C12-BA27-1B707118CC79

P433

Q34594898-4220C01E-88A7-4882-89A6-8ACE52737259

P478

Q34594898-7D95E291-CEB4-450C-87BE-2965107A527E

P50

Q34594898-C819AC79-7699-4927-A279-F2EF5B5F70BA

P577

Q34594898-22BC8734-08E2-4BD1-8844-D57D6B6D5176

P698

Q34594898-FDAE66A9-7426-4AE8-8BB3-B625C44622E5

P932

Q34594898-D1A8B364-950C-40C9-A9FE-09462D5FB1E0

P356

P1433

Journal of Virology

P1476

Recombinant modified vaccinia ...... hanced innate immune responses

@en

P2093

Hubertus Hochrein

http://www.w3.org/2001/XMLSchema#string

Jürgen Hausmann

http://www.w3.org/2001/XMLSchema#string

Kay Brinkmann

http://www.w3.org/2001/XMLSchema#string

Marc Schweneker

http://www.w3.org/2001/XMLSchema#string

Marieken Klingenberg

http://www.w3.org/2001/XMLSchema#string

Mark Suter

http://www.w3.org/2001/XMLSchema#string

Michael Wolferstätter

http://www.w3.org/2001/XMLSchema#string

Michaela Späth

http://www.w3.org/2001/XMLSchema#string

Paul Chaplin

http://www.w3.org/2001/XMLSchema#string

Susanne Lukassen

http://www.w3.org/2001/XMLSchema#string

P2860

A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses

IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA

Inhibition of IkappaB kinase by vaccinia virus virulence factor B14

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase

New insights into the role of RNase L in innate immunity

Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated

Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action

West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR

The RNA-activated Protein Kinase Enhances the Induction of Interferon- and Apoptosis Mediated by Cytoplasmic RNA Sensors

P304

14396-14411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02082-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Henning Lauterbach

P577

2014-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25297997

http://www.w3.org/2001/XMLSchema#string

P932

4249137

http://www.w3.org/2001/XMLSchema#string